| Q27693330 | 'As above, so below' examining the interplay between emotion and the immune system |
| Q38310117 | 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders |
| Q38530324 | A Case Report of Improvement in Crohn's Disease-related Symptoms Following Participation in a Comprehensive Mind-Body Program |
| Q60927377 | A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model |
| Q64091997 | A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme |
| Q34998108 | Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study |
| Q53477304 | Aggravation of Established Colitis in Specific Pathogen-free IL-10 Knockout Mice by Restraint Stress Is Not Mediated by Increased Colonic Permeability. |
| Q47712418 | Alterations in brain grey matter structures in patients with crohn's disease and their correlation with psychological distress |
| Q47131337 | Altered Neuroendocrine Immune Responses, a Two-Sword Weapon against Traumatic Inflammation |
| Q40535602 | Altered sympathovagal balance and pain hypersensitivity in TNBS-induced colitis |
| Q93016374 | Alternative & complementary treatment for pediatric inflammatory bowel disease |
| Q44449819 | Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. |
| Q48338237 | Antidepressant use among paediatric patients with recent-onset inflammatory bowel disease: a nationwide case control study in Finland |
| Q92897746 | Anxiety Disorders and General Medical Conditions: Current Research and Future Directions |
| Q90011779 | Approach to stress endocrine response: somatization in the context of gastroenterological symptoms: a systematic review |
| Q37344968 | Assessing the Relationship between Sources of Stress and Symptom Changes among Persons with IBD over Time: A Prospective Study. |
| Q48356972 | Attachment and perceived stress in patients with ulcerative colitis, a case-control study |
| Q30374507 | Autonomic effects of music in health and Crohn's disease: the impact of isochronicity, emotional valence, and tempo |
| Q51751141 | Autonomic nervous system function predicts the inflammatory response over three years in newly diagnosed ulcerative colitis patients. |
| Q35850091 | Basal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection |
| Q60045680 | Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke |
| Q90054954 | Brain Resting-State Network Alterations Associated With Crohn's Disease |
| Q36404766 | Brain changes detected by functional magnetic resonance imaging and spectroscopy in patients with Crohn's disease |
| Q41415186 | Brain micro-inflammation at specific vessels dysregulates organ-homeostasis via the activation of a new neural circuit. |
| Q48778691 | Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI study. |
| Q26784403 | Brain-gut-microbiota axis in Parkinson's disease |
| Q27340307 | Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4+CD25- T cells in experimental colitis |
| Q30384107 | Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. |
| Q48875226 | Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. |
| Q54402209 | Combined Effects of M1 Muscarinic Acetylcholine Receptor Agonist TBPB and α7n-Acetylcholine Receptor Activator GTS-21 on Mouse Mortality and Blood Concentration of Proinflammatory Cytokines in Sepsis. |
| Q35755435 | Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways |
| Q47102465 | Connecting the Mind-Body Split: Understanding the Relationship between Symptoms and Emotional Well-Being in Chronic Pain and Functional Gastrointestinal Disorders |
| Q91919781 | Copy number variation-based gene set analysis reveals cytokine signalling pathways associated with psychiatric comorbidity in patients with inflammatory bowel disease |
| Q36253681 | Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish |
| Q35824899 | Cromolyn-mediated improvement of intestinal barrier function is associated with enhanced piglet performance after weaning |
| Q47202406 | Curcumin attenuates collagen-induced inflammatory response through the "gut-brain axis". |
| Q55025675 | Cyclic AMP signaling enhances lipopolysaccharide sensitivity and interleukin-33 production in RAW264.7 macrophages. |
| Q35728129 | Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice |
| Q49721596 | Difference in regional neural fluctuations and functional connectivity in Crohn's disease: a resting-state functional MRI study. |
| Q47169503 | Differences in brain gray matter volume in patients with Crohn's disease with and without abdominal pain |
| Q37143425 | Differences in regional homogeneity between patients with Crohn's disease with and without abdominal pain revealed by resting-state functional magnetic resonance imaging |
| Q37421640 | Different brain responses to electro-acupuncture and moxibustion treatment in patients with Crohn's disease |
| Q35560462 | Diminished vagal tone is a predictive biomarker of necrotizing enterocolitis-risk in preterm infants. |
| Q27330156 | Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics? |
| Q35737216 | Early Life Experience and Gut Microbiome: The Brain-Gut-Microbiota Signaling System |
| Q35624810 | Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease |
| Q91729762 | Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial |
| Q47567635 | Effect of Electro-Acupuncture and Moxibustion on Brain Connectivity in Patients with Crohn's Disease: A Resting-State fMRI Study |
| Q38839757 | Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis |
| Q36216726 | Effect of venlafaxine on experimental colitis in normal and reserpinised depressed rats |
| Q88930402 | Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial |
| Q38804641 | Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (H |
| Q93377119 | Enriched environment on the intestinal mucosal barrier and brain-gut axis in rats with colorectal cancer |
| Q38366954 | Epidemiology and risk factors for IBD. |
| Q38950426 | Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease |
| Q39403183 | Exercise and gut microbiota: clinical implications for the feasibility of Tai Chi. |
| Q26772836 | Exosomes as Novel Regulators of Adult Neurogenic Niches |
| Q92290145 | Experimental colitis reduces microglial cell activation in the mouse brain without affecting microglial cell numbers |
| Q37426460 | Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats |
| Q33649866 | Fatigue in patients with inflammatory bowel disease is associated with distinct differences in immune parameters. |
| Q59330192 | From Gut to Brain: Alteration in Inflammation Markers in the Brain of Dextran Sodium Sulfate-induced Colitis Model Mice |
| Q46118752 | Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. |
| Q36252576 | Genome-Wide Immune Modulation of TLR3-Mediated Inflammation in Intestinal Epithelial Cells Differs between Single and Multi-Strain Probiotic Combination |
| Q93018171 | Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study |
| Q28070141 | Gut Microbiome and Infant Health: Brain-Gut-Microbiota Axis and Host Genetic Factors |
| Q47111758 | Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review |
| Q58694401 | Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review |
| Q35320851 | Gut microbiota, the immune system, and diet influence the neonatal gut-brain axis |
| Q34743223 | Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis |
| Q55605649 | Harnessing the Power of Microbiome Assessment Tools as Part of Neuroprotective Nutrition and Lifestyle Medicine Interventions. |
| Q38869028 | Heart Rate Recovery Is Impaired in Patients with Inflammatory Bowel Diseases |
| Q47417355 | Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures. |
| Q92860876 | Hippocampal neural stem cells and microglia response to experimental inflammatory bowel disease (IBD) |
| Q36198753 | Human gut microbiota: the links with dementia development |
| Q38517245 | Hypnotherapy for Inflammatory Bowel Disease Across the Lifespan |
| Q28087215 | Impact of the gut microbiota on rodent models of human disease |
| Q30402076 | Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain |
| Q63816182 | Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease |
| Q35222879 | Inflammatory bowel disease and anxiety: links, risks, and challenges faced |
| Q64230518 | Influence of Environmental Factors in the Development and Outcomes of Inflammatory Bowel Disease |
| Q92000836 | Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome |
| Q92864248 | Interrogating the Gut-Brain Axis in the Context of Inflammatory Bowel Disease: A Translational Approach |
| Q64246397 | Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis |
| Q55069382 | Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease. |
| Q41046334 | Intrinsic neural network dysfunction in quiescent Crohn's Disease. |
| Q34924354 | Involvement of MAPK/NF-κB signaling in the activation of the cholinergic anti-inflammatory pathway in experimental colitis by chronic vagus nerve stimulation |
| Q38840251 | Involvement of Mast Cells in α7 Nicotinic Receptor Agonist Exacerbation of Freund's Complete Adjuvant-Induced Monoarthritis in Mice |
| Q57463011 | Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats |
| Q39148827 | Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress |
| Q55035832 | Isoform-specific regulation of transforming growth factor-β mRNA expression in macrophages in response to adrenoceptor stimulation. |
| Q28539860 | Job strain and the risk of inflammatory bowel diseases: individual-participant meta-analysis of 95,000 men and women |
| Q34363640 | Key role of CRF in the skin stress response system |
| Q36604130 | Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective |
| Q90416308 | Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist |
| Q34048040 | Managing irritable bowel syndrome: The impact of micro-physiotherapy |
| Q34536133 | Maternal exposure to low levels of corticosterone during lactation protects against experimental inflammatory colitis-induced damage in adult rat offspring |
| Q91650848 | Microbiota-gut-brain axis and its affect inflammatory bowel disease: Pathophysiological concepts and insights for clinicians |
| Q93145936 | Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health Status |
| Q33607860 | Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. |
| Q42874439 | Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis? |
| Q55266163 | Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis. |
| Q58721972 | Neurotransmitter alterations in the anterior cingulate cortex in Crohn's disease patients with abdominal pain: A preliminary MR spectroscopy study |
| Q53016429 | Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice. |
| Q26738543 | Omnivores Going Astray: A Review and New Synthesis of Abnormal Behavior in Pigs and Laying Hens |
| Q44350905 | Opioid misuse in gastroenterology and non-opioid management of abdominal pain |
| Q38997203 | Opioids and GI Motility-Friend or Foe? |
| Q58125133 | Optimizing the multidimensional aspects of the patient-physician relationship in the management of inflammatory bowel disease |
| Q92528528 | Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study |
| Q34498319 | Pediatric inflammatory bowel disease and depression: treatment implications |
| Q58606329 | Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis |
| Q48038691 | Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients |
| Q39207016 | Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers. |
| Q45331934 | Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort |
| Q34356034 | Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice |
| Q36056969 | Progress in the treatment and outcome of pediatric inflammatory bowel disease patients |
| Q55491567 | Promoter methylation of the MGAT3 and BACH2 genes correlates with the composition of the immunoglobulin G glycome in inflammatory bowel disease. |
| Q37682510 | Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease |
| Q90047017 | Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up |
| Q36210029 | Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life |
| Q44572735 | Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism |
| Q38491460 | Quality of methods reporting in animal models of colitis |
| Q35906057 | RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives |
| Q33922847 | Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease |
| Q34160082 | Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome |
| Q96348665 | Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trial |
| Q93051834 | Review: Link between intestinal immunity and practical approaches to swine nutrition |
| Q64894301 | Risk of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Nationwide, Population-Based Study. |
| Q50074255 | Role of β2-Adrenoreceptors in Adrenergic Anti-Inflammatory Mechanism in Sepsis |
| Q30658529 | Stereomicroscopic 3D-pattern profiling of murine and human intestinal inflammation reveals unique structural phenotypes |
| Q47708577 | Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study |
| Q35867820 | Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome |
| Q35087100 | Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities |
| Q39944908 | Subacute stress and chronic stress interact to decrease intestinal barrier function in rats. |
| Q38404037 | Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks? |
| Q36182979 | The Central Nervous System and the Gut Microbiome. |
| Q90365226 | The Costs of Living Together: Immune Responses to the Microbiota and Chronic Gut Inflammation |
| Q41278499 | The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial |
| Q40566816 | The Gut's Little Brain in Control of Intestinal Immunity |
| Q64935645 | The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. |
| Q58123751 | The Microbiome and Preterm Birth: A Change in Paradigm with Profound Implications for Pathophysiologic Concepts and Novel Therapeutic Strategies |
| Q55000938 | The Neurodevelopmental Perspective of Surgical Necrotizing Enterocolitis: The Role of the Gut-Brain Axis. |
| Q26774660 | The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease |
| Q38865932 | The Realization of the Brain-Gut Interactions with Corticotropin-Releasing Factor and Glucocorticoids |
| Q34526079 | The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course |
| Q54269133 | The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. |
| Q45040278 | The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. |
| Q37448259 | The causal representation of outpatients with Crohn's disease: is there a link between psychological distress and clinical disease activity? |
| Q91739350 | The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial |
| Q26765284 | The epidemiology and risk factors of inflammatory bowel disease |
| Q37552936 | The holistic effects of acupuncture treatment |
| Q35838055 | The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome. |
| Q43564722 | The link between negative affect, vagal tone, and visceral sensitivity in quiescent Crohn's disease |
| Q35878852 | The microbiome and childhood diseases: Focus on brain-gut axis |
| Q35054658 | The microbiome: stress, health and disease |
| Q27026764 | The multifaceted mast cell in inflammatory bowel disease |
| Q38248064 | The narcotic bowel syndrome: a recent update |
| Q38211208 | The role of hypnotherapy for the treatment of inflammatory bowel diseases |
| Q28304749 | The role of microbiome in central nervous system disorders |
| Q40830748 | The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission |
| Q47425661 | The stress concept in gastroenterology: from Selye to today |
| Q37467983 | Tolerance Limits, Self-understanding, and Stress Resilience in Integrative Recovery of Inflammatory Bowel Disease |
| Q26798003 | Towards a systems view of IBS |
| Q92012606 | Transcriptome-Guided Drug Repositioning |
| Q39106259 | Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and tumor necrosis factor-alpha. |
| Q48200009 | Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease |
| Q99349994 | Ulcerative colitis |
| Q38787059 | Vagal tone: effects on sensitivity, motility, and inflammation |
| Q39250092 | Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease |
| Q26858806 | Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway |
| Q26748620 | What goes around comes around: novel pharmacological targets in the gut-brain axis |